Glycogen-rich clear cell carcinoma of the breast

by Hatzinikolaou ML, Antonopoulou Zoi, Kouskos Efstatios, Philipidis T, Mantas Dimitris, Markopoulos Christos, Gogas Helen
Published 2008-04-01

Evaluation of six CTLA-4 polymorphisms in high-risk melanoma patients receiving adjuvant interferon therapy in the He13A/98 multicenter trial

by Fountzilas George, Panagiotou Petros, Markopoulos Christos, Stratigos Alexandros, Polyzos Aristidis, Tsoutsos Dimosthenis, Pectasides Eirini, Buchbinder Elizabeth, Metaxas Yannis, Spyropoulou-Vlachou Maria, Koon Henry, Dafni Urania, Gogas Helen, Castana Ourania, Skarlos Pantelis, Atkins Michael B, Kirkwood John M
Published 2010-11-01

HER2 and TOP2A in high-risk early breast cancer patients treated with adjuvant epirubicin-based dose-dense sequential chemotherapy

by Fountzilas George, Valavanis Christos, Kotoula Vassiliki, Eleftheraki Anastasia G, Kalogeras Konstantine T, Tzaida Olympia, Batistatou Anna, Kronenwett Ralf, Wirtz Ralph M, Bobos Mattheos, Timotheadou Eleni, Soupos Nikolaos, Pentheroudakis George, Gogas Helen, Vlachodimitropoulos Dimitrios, Polychronidou Genovefa, Aravantinos Gerasimos, Koutras Angelos, Christodoulou Christos, Pectasides Dimitrios, Arapantoni Petroula
Published 2012-01-01

FUTURE PERSPECTIVES IN MELANOMA RESEARCH. Meeting report from the “Melanoma Research: a bridge from Naples to the World. Napoli, December 5^th–6 ^th2011”

by Ascierto Paolo A, Grimaldi Antonio M, Curti Brendan, Faries Mark B, Ferrone Soldano, Flaherty Keith, Fox Bernard A, Gajewski Thomas F, Gershenwald Jeffrey E, Gogas Helen, Grossmann Kenneth, Hauschild Axel, Hodi F, Kefford Richard, Kirkwood John M, Leachmann Sancy, Maio Michele, Marais Richard, Palmieri Giuseppe, Morton Donald L, Ribas Antoni, Stroncek David F, Stewart Rodney, Wang Ena, Mozzillo Nicola, Marincola Franco M
Published 2012-07-01